FDA recall, , Moderate risk
Steris Rapicide PA Part A High-Level Disinfectant
Rapicide PA Part A High-Level Disinfectant may swell if its vented cap is blocked, and could expose users to vapor or liquid.
What happened
Steris Corporation recalled Rapicide PA Part A High-Level Disinfectant on September 21, 2026, because if the vented cap becomes blocked, gas may accumulate and the bottle may swell due to increased internal pressure.
In some cases, excess vapor or liquid chemistry may escape from the bottle when the cap is twisted during opening, which could result in user exposure if required personal protective equipment (PPE) is not properly used. The recall was added to the FDA's Enforcement Report on October 14, 2026, with worldwide - US nationwide distribution.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Match your product and all the details in one listed combination.
A UDI-DI is the device identifier printed with the barcode on the device label.
Rapicide PA Part A High-Level Disinfectant, Model/
- UDI-DI
- 00724995245658
- Catalog code
- ML020115
- UDI-DI
- 00724995245962
- Catalog code
- ML020117
- UDI-DI
- 00724995245955
- Catalog code
- ML020116
Recall details
- Company began the recall
- Sold in
Worldwide - US Nationwide distribution.
- Company
- Steris Corporation
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99804
- Recall numbers
- Z-0154-2027 to Z-0156-2027
All recalls from Steris Corporation
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report



